PharmiWeb.com - Global Pharma News & Resources
25-Jun-2019

Animal Drug Compounding Market is expected to reach USD 1370 million Lucrative at a CAGR 6.2% by the year 2025

New report published by Ameco Research which offers Exclusive Research ldquo;Global Animal Drug Compounding Market Insights, Forecast to 2025rdquo;.

The Global Animal Drug Compounding Market is valued at 840 million US$ in 2018 and will reach 1370 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Animal Drug Compounding market based on company, product type, end user and key regions.

The Global Animal Drug Compounding Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2025. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2019 to 2025.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/13735

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Animal Drug Compounding Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Animal Drug Compounding Market?

What is the market drivers, restrains, opportunities governing the Global Animal Drug Compounding Market?

Which are the largest and the fastest growing segments in the Global Animal Drug Compounding Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as "customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in theanimal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market/global-animal-drug-compounding-market-arr-13735

This report studies the global market size of Animal Drug Compounding in key regions like North America, Europe, Asia Pacific, Central amp; South America and Middle East amp; Africa, focuses on the consumption of Animal Drug Compounding in these regions.
This research report categorizes the global Animal Drug Compounding market by top players/brands, region, type and end user. This report also studies the global Animal Drug Compounding market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET

Market size by Product
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Market size by End User
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central amp; South America
Brazil
Rest of Central amp; South America
Middle East amp; Africa
GCC Countries
Turkey
Egypt
South Africa

Few Significant from Table Of Contents

Global Animal Drug Compounding Market Insights, Forecast to 2025

1 Study Coverage
1.1 Animal Drug Compounding Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Animal Drug Compounding Market Size Growth Rate by Product
1.4.2 Anti-Infective Agents
1.4.3 Hormones and Substitutes
1.4.4 Anti-Inflammatory Agents
1.4.5 Others
1.5 Market by End User
1.5.1 Global Animal Drug Compounding Market Size Growth Rate by End User
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Veterinary Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Animal Drug Compounding Market Size
2.1.1 Global Animal Drug Compounding Revenue 2014-2025
2.1.2 Global Animal Drug Compounding Sales 2014-2025
2.2 Animal Drug Compounding Growth Rate by Regions
2.2.1 Global Animal Drug Compounding Sales by Regions
2.2.2 Global Animal Drug Compounding Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Animal Drug Compounding Sales by Manufacturers
3.1.1 Animal Drug Compounding Sales by Manufacturers
3.1.2 Animal Drug Compounding Sales Market Share by Manufacturers
3.1.3 Global Animal Drug Compounding Market Concentration Ratio (CR5 and HHI)
3.2 Animal Drug Compounding Revenue by Manufacturers
3.2.1 Animal Drug Compounding Revenue by Manufacturers (2014-2019)
3.2.2 Animal Drug Compounding Revenue Share by Manufacturers (2014-2019)
3.3 Animal Drug Compounding Price by Manufacturers
3.4 Animal Drug Compounding Manufacturing Base Distribution, Product Types
3.4.1 Animal Drug Compounding Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Drug Compounding Product Type
3.4.3 Date of International Manufacturers Enter into Animal Drug Compounding Market
3.5 Manufacturers Mergers amp; Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Animal Drug Compounding Sales by Product
4.2 Global Animal Drug Compounding Revenue by Product
4.3 Animal Drug Compounding Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Animal Drug Compounding Breakdown Data by End User

6 North America
6.1 North America Animal Drug Compounding by Countries
6.1.1 North America Animal Drug Compounding Sales by Countries
6.1.2 North America Animal Drug Compounding Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Animal Drug Compounding by Product
6.3 North America Animal Drug Compounding by End User

7 Europe
7.1 Europe Animal Drug Compounding by Countries
7.1.1 Europe Animal Drug Compounding Sales by Countries
7.1.2 Europe Animal Drug Compounding Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal Drug Compounding by Product
7.3 Europe Animal Drug Compounding by End User

8 Asia Pacific
8.1 Asia Pacific Animal Drug Compounding by Countries
8.1.1 Asia Pacific Animal Drug Compounding Sales by Countries
8.1.2 Asia Pacific Animal Drug Compounding Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Animal Drug Compounding by Product
8.3 Asia Pacific Animal Drug Compounding by End User

9 Central amp; South America
9.1 Central amp; South America Animal Drug Compounding by Countries
9.1.1 Central amp; South America Animal Drug Compounding Sales by Countries
9.1.2 Central amp; South America Animal Drug Compounding Revenue by Countries
9.1.3 Brazil
9.2 Central amp; South America Animal Drug Compounding by Product
9.3 Central amp; South America Animal Drug Compounding by End User

10 Middle East and Africa
10.1 Middle East and Africa Animal Drug Compounding by Countries
10.1.1 Middle East and Africa Animal Drug Compounding Sales by Countries
10.1.2 Middle East and Africa Animal Drug Compounding Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Animal Drug Compounding by Product
10.3 Middle East and Africa Animal Drug Compounding by End User

11 Company Profiles
11.1 Triangle Compounding Pharmacy
11.1.1 Triangle Compounding Pharmacy Company Details
11.1.2 Company Business Overview
11.1.3 Triangle Compounding Pharmacy Animal Drug Compounding Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Triangle Compounding Pharmacy Animal Drug Compounding Products Offered
11.1.5 Triangle Compounding Pharmacy Recent Development
11.2 Lorraine's Pharmacy
11.2.1 Lorraine's Pharmacy Company Details
11.2.2 Company Business Overview
11.2.3 Lorraine's Pharmacy Animal Drug Compounding Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Lorraine's Pharmacy Animal Drug Compounding Products Offered
11.2.5 Lorraine's Pharmacy Recent Development
11.3 Medisca
11.3.1 Medisca Company Details
11.3.2 Company Business Overview
11.3.3 Medisca Animal Drug Compounding Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Medisca Animal Drug Compounding Products Offered
11.3.5 Medisca Recent Development
11.4 Diamondback Drugs
11.4.1 Diamondback Drugs Company Details
11.4.2 Company Business Overview
11.4.3 Diamondback Drugs Animal Drug Compounding Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Diamondback Drugs Animal Drug Compounding Products Offered
11.4.5 Diamondback Drugs Recent Development
11.5 ESSENTIAL PHARMACY COMPOUNDING VET
11.5.1 ESSENTIAL PHARMACY COMPOUNDING VET Company Details
11.5.2 Company Business Overview
11.5.3 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Sales, Revenue and Gross Margin (2014-2019)
11.5.4 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Products Offered
11.5.5 ESSENTIAL PHARMACY COMPOUNDING VET Recent Development

...

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/13735

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 25-Jun-2019